Vericel
VCEL
40.74
+0.69
+1.72%
Vericel
US · VCEL
#2759 by market cap
Listed 1970
40.74
+0.69
+1.72%
Live - 5344 symbols - heartbeat 461s ago
· 2026-10-08 04:26
Pre-market
40.69
-0.12%
After-hours
40.74
0.00%
- Market cap
- 2.09B
- P/E (TTM)i
- 84.88
- P/Bi
- 5.64
- EPSi
- 0.32
- Div yieldi
- 0.00%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on VCEL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- Total institutional ownership rose 0.7 percentage points.
Institutional ownership
- Held by institutions
- 111.57% +0.70pp
- Institutions
- 383
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund93.54%
Hedge Fund9.95%
Public Company4.00%
Private Company1.27%
Insurance Company1.26%
Individual/Insider1.19%
Government Pension Fund1.19%
Sovereign Wealth Fund0.19%
Family Office/Trust0.12%
Top holders as of 2026-06-30
BlackRock
15.80% · 8.09M sh
State Street Global Advisors
6.43% · 3.29M sh
Congress Asset Management Company, LLP
5.70% · 2.92M sh
Vanguard Capital Management, LLC
5.12% · 2.62M sh
Conestoga Capital Advisors, LLC
4.07% · 2.08M sh
William Blair Investment Management, LLC
3.89% · 1.99M sh
BNPP Asset Management Holding
3.20% · 1.64M sh
GW&K Investment Management, LLC
3.03% · 1.55M sh
Soleus Capital Management, L.P.
2.85% · 1.46M sh
Geode Capital Management, LLC
2.62% · 1.34M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 26 sells
| Name | Role | Stake |
|---|---|---|
| Dominick Colangelo | Chief Executive Officer | 0.61% |
| Jonathan Hopper | Chief Medical Officer | 0.15% |
| Alan Rubino | Independent Director | 0.13% |
| Heidi Hagen | Independent Director | 0.07% |
| Robert Zerbe | Independent Chairperson | 0.06% |
| Paul Wotton | Independent Director | 0.04% |
| Kevin McLaughlin | Independent Director | 0.04% |
| Michael Halpin | Chief Operating Officer | 0.03% |
| Joseph Mara | Chief Financial Officer | 0.03% |
| Lisa Wright | Independent Director | 0.03% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-11 | Kevin McLaughlin | Independent Director | Derivative Exercise and Sale | -7,000 | $13.05–44.53 |
| 2026-08-02 | Michael Halpin | Chief Operating Officer | Derivative Exercise and Sale | -10,000 | $16.66–46.84 |
| 2026-07-29 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Derivative Exercise and Sale | -4,500 | $29.82–48.90 |
| 2026-06-25 | Jonathan Hopper | Chief Medical Officer | Derivative Exercise and Sale | -10,000 | $29.82–45.00 |
| 2026-06-25 | Sean Flynn | Senior Vice President | Derivative Exercise and Sale | -15,000 | $16.25–45.64 |
| 2026-06-25 | Joseph Mara | Chief Financial Officer | Automatic Disposition | -5,000 | $44.75 |
| 2026-06-25 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Automatic Disposition | -232 | $44.90 |
| 2026-06-25 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Derivative Exercise and Sale | -2,500 | $29.82–44.90 |
| 2026-06-17 | Michael Halpin | Chief Operating Officer | Derivative Exercise and Sale | -10,000 | $16.66–40.24 |
| 2026-06-17 | Sean Flynn | Senior Vice President | Derivative Exercise and Sale | -15,000 | $16.25–40.21 |
| 2026-06-01 | Jonathan Hopper | Chief Medical Officer | Derivative Exercise and Sale | -4,375 | $16.66–35.00 |
| 2026-05-12 | Kevin McLaughlin | Independent Director | Derivative Exercise and Sale | -7,000 | $2.63–32.83 |
| 2026-05-12 | Kevin McLaughlin | Independent Director | Other Derivative Acquisition | +7,000 | $2.63–13.05 |
| 2026-05-10 | Paul Wotton | Independent Director | Open Market Disposition | -10,000 | $32.64–33.05 |
| 2026-05-06 | Joseph Mara | Chief Financial Officer | Automatic Disposition | -5,000 | $40.50 |
| 2026-05-06 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Automatic Disposition | -4,855 | $38.00–40.50 |
| 2026-05-06 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Intent to Sell (Form 144) | -1,422 | $40.50 |
| 2026-05-05 | Jonathan Siegal | Principal Accounting Officer, VP & Corporate Controller | Intent to Sell (Form 144) | -3,433 | $38.00 |
| 2026-04-28 | Kevin McLaughlin | Independent Director | Other Derivative Acquisition | +3,200 | -- |
| 2026-04-28 | Kevin McLaughlin | Independent Director | Other Derivative Acquisition | +8,000 | $33.43 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:26:33 · For reference only, not investment advice and not tailored to your situation.